Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.

Metabolism: clinical and experimental - 1 Jan 2013

Vanitallie Theodore B

Abstract excerpt

The most opportune time for preventive intervention in sporadic Alzheimer's disease (spAD) is early in its preclinical stage (pcAD), when the odds of preventing or minimizing later disabling neurodegeneration are most favorable. The efficacy of promising preventive interventions should be assessed in patients in the earliest discernible phase of pcAD. This will require application of personalized medicine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Cellular Senescence
Share to Early Diagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Mass Screening

Share to Neuroimaging

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Source

Identifiers

PMID: 23021038
DOI: 10.1016/j.metabol.2012.08.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.PMID 23021038Read ↗

Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.Semantic proximity Read ↗

Characterizing the Preclinical Stages of Alzheimer's Disease and the Prospect of Presymptomatic InterventionSemantic proximity Read ↗

Differential diagnosis and early detection of dementia.Semantic proximity Read ↗

Alzheimer’s disease: diagnostics, prognostics and the road to preventionSemantic proximity Read ↗

Molecular imaging in sporadic Alzheimer's disease populations and those genetically at risk.Semantic proximity Read ↗

Preclinical Alzheimer disease-the challenges ahead.Semantic proximity Read ↗

Presymptomatic apolipoprotein E genotyping for Alzheimer's disease risk assessment and prevention.Semantic proximity Read ↗

Population-Based Approaches to Alzheimer's Disease Prevention.Semantic proximity Read ↗

Diagnostic approaches to Alzheimer's disease.Semantic proximity Read ↗

Midlife interventions are critical in prevention, delay, or improvement of Alzheimer’s disease and vascular cognitive impairment and dementiaSemantic proximity Read ↗

Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.Semantic proximity Read ↗

Future scenarios for the prevention and delay of Alzheimer disease onset in high-risk groups. An ethical perspective.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.